Page 7 - Regarding Use News Today

FREMONT, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) today reported financial results for the second quarter ended June 30, 2023.

   For the three-month period ended June 30, 2022 For the three-month period ended June 30, 2023$ in thousands Plants TherapeuticsTotal reportable segments Plants TherapeuticsTotal reportable...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the second quarter ended June 30, 2023. Key highl...

Revenues increased 16 percent sequentially to $123.2 million; GAAP earnings were $0.26 per diluted share; non-GAAP earnings were $0.36 per diluted share ...

27.07.2023 - DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2023. Second Quarter 2023 Financial Highlights: Revenue grew 25% versus the same quarter of the prior year to $871.3 million on a reported ...

ServiceNow exceeds guidance across all Q2 2023 topline growth and profitability metrics; raises 2023 subscription revenues and operating margin guidance Subscription revenues of $2,075 million in...

/PRNewswire/ -- B. Riley Financial, Inc. (NASDAQ: RILY) ("B. Riley" or the "Company"), a diversified financial services platform, today announced certain...

Global Infrared Imaging Technology Strategic Business Report 2023: Rising Significance of IR Technology in Industrial Imaging Applications

/PRNewswire/ -- The "Infrared Imaging Technology: Global Strategic Business Report" report has been added to ResearchAndMarkets.coms offering. The global...

Total Revenue for Fiscal 2022 Increased 20% Year Over Year; Company Guides for Continued Revenue and Earnings Growth in Fiscal 2023